| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CAY10576 | CTRPv2 | pan-cancer | AAC | 0.0028 | 0.9 |
| mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | -0.0025 | 0.9 |
| mRNA | triptolide | CTRPv2 | pan-cancer | AAC | 0.0022 | 1 |
| mRNA | SCH-529074 | CTRPv2 | pan-cancer | AAC | -0.0021 | 1 |
| mRNA | BRD-K99006945 | CTRPv2 | pan-cancer | AAC | 0.0021 | 1 |
| mRNA | BRD-K30019337 | CTRPv2 | pan-cancer | AAC | -0.0028 | 1 |
| mRNA | tanespimycin:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0014 | 1 |
| mRNA | salermide | CTRPv2 | pan-cancer | AAC | 0.0017 | 1 |
| mRNA | VU0155056 | CTRPv2 | pan-cancer | AAC | -0.0013 | 1 |
| mRNA | AZD6244 | CTRPv2 | pan-cancer | AAC | 0.0012 | 1 |